Oral and intravenous fosfomycin in complicated urinary tract infections

Mostra el registre complet Registre parcial de l'ítem

• dc.contributor.author López Montesinos, Inmaculada
• dc.contributor.author Horcajada Gallego, Juan Pablo
• dc.date.accessioned 2020-04-14T07:12:45Z
• dc.date.available 2020-04-14T07:12:45Z
• dc.date.issued 2019
• dc.description.abstract Urinary tract infections are one of the most common health problems and entail a high consumption of health system resources. Due to the increase in global antibiotic resistances in recent years, it is increasingly common to find uropathogens with multiple resistance mechanisms, including quinolone-resistant bacteria, broad-spectrum β-lactamase producers and carbapenemase producers. In this scenario, the role of fosfomycin has gained considerable importance, given its spectrum of activity against multidrug resistant microorganisms (Gram-positive and Gram-negative), becoming an attractive alternative therapy. Regarding the use of fosfomycin in complicated urinary tract infections, there is increasing clinical experience with patients with infections caused by multidrug resistant bacteria, those with recurrent urinary tract infection and special populations such as those with kidney transplants. Randomized comparative studies and series are underway, which will provide greater evidence. Nevertheless, more studies are needed to confirm the enormous potential of fosfomycin in complicated urinary tract infection in the era of multiresistance.
• dc.format.mimetype application/pdf
• dc.identifier.citation López-Montesinos I, Horcajada JP. Oral and intravenous fosfomycin in complicated urinary tract infections. Rev Esp Quimioter. 2019 May; 32 Suppl 1(Suppl 1): 37-44.
• dc.identifier.issn 0214-3429
• dc.identifier.uri http://hdl.handle.net/10230/44201
• dc.language.iso eng
• dc.publisher Sociedad Española de Quimioterapia
• dc.relation.ispartof Sociedad Española de Quimioterapia. 2019 May; 32 Suppl 1(Suppl 1): 37-44
• dc.rights Copyright © The Author 2019. The article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) (https://creativecommons.org/licenses/by-nc/4.0/)
• dc.rights.accessRights info:eu-repo/semantics/openAccess
• dc.rights.uri http://creativecommons.org/licenses/by-nc/4.0/
• dc.subject.other Infeccions -- Tractament
• dc.subject.other Urologia -- Malalties
• dc.subject.other Aparell urinari -- Infeccions -- Tractament
• dc.title Oral and intravenous fosfomycin in complicated urinary tract infections
• dc.type info:eu-repo/semantics/article
• dc.type.version info:eu-repo/semantics/publishedVersion